Table 1.

Patient characteristics.

Characteristic	All study participants (N = 39)*
Age, median (range), years	35 (18–68)
Sex
Female	21 (54%)
Male	18 (46%)
Type of primary immunodeficiency
Common variable immunodeficiency Unspecified hypogammaglobulinemia X-linked or recessive agammaglobulinemia Antibody deficiency due to congenital defect Specific antibody deficiency with bronchiectasis Hyperglobulinemia with infections	27 (71%) 5 (13%) 3 (8%) 2 (5%) 1 (3%) 1 (3%)
Disease duration, median (range), years	10 (1–41)
Place of living
Big city Small city Village	25 (64%) 11 (28%) 3 (8%)
Education level
High Secondary Basic	18 (46%) 14 (36%) 7 (18%)
Professional activity
Professionally active (working/studying) Disability benefit	24 (62%) 15 (38%)
IgG replacement therapy before fSCIG
Only IVIG IVIG>SCIG Only SCIG IgG naïve	23 (59%) 9 (23%) 5 (13%) 2 (5%)

^*All data are presented as n (%), unless otherwise indicated.

fSCIG, facilitated subcutaneous immunoglobulin; IVIG, intravenous immunoglobulin; SCIG, subcutaneous immunoglobulin.